Clinical Trial Update: CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial from the University of Sao Paulo evaluating a CD19-directed CAR-T cell therapy for relapsed/refractory acute lymphoblastic leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• CD19-directed CAR-T cell therapy

Snippet

Sponsor: University of Sao Paulo | Conditions: Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin | Phase 1, Phase 2 | Status: RECRUITING